During the past decade, Bridge HIV conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Bridge HIV" are "Healthy" (2 trials). Many other conditions were trialed in "Bridge HIV" in a lesser frequency.

Most popular intervention types in "Bridge HIV" are "Biological" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ad26.Mos4.HIV" (2 trials), "Placebo" (2 trials), "Clade C and Mosaic gp140 HIV bivalent vaccine" (1 trials), "Clade C gp140 plus adjuvant" (1 trials) and "Clade C gp140/Mosaic gp140 plus adjuvant" (1 trials). Other intervention names were less common.

The vast majority of trials in "Bridge HIV" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Bridge HIV". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Bridge HIV, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Bridge HIV, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".